These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7767254)

  • 21. Chemotherapy dose and survival in advanced Hodgkin's disease.
    Gerhartz HH; Beykirch M; Hiller E; Wilmanns W
    Acta Haematol; 1993; 89(3):137-40. PubMed ID: 7689778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term evolution in Hodgkin's disease.
    Somers R
    Pathol Biol (Paris); 1993 Jan; 41(1):100-1. PubMed ID: 8316440
    [No Abstract]   [Full Text] [Related]  

  • 23. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.
    Horning SJ; Hoppe RT; Breslin S; Bartlett NL; Brown BW; Rosenberg SA
    J Clin Oncol; 2002 Feb; 20(3):630-7. PubMed ID: 11821442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternating chemotherapy and radiation therapy in the treatment of advanced Hodgkin's disease.
    Grigoraki V; Merle-Beral H; Touboul E; Gabarre J; Lesty C; Binet JL
    Nouv Rev Fr Hematol (1978); 1988; 30(4):219-24. PubMed ID: 3194187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The chemotherapeutic treatment of advanced Hodgkin's disease].
    Epelbaum R; Haim N; Ben-Shahar M; Valtuch I; Faraggi D; Sharabi-Nov A; Ben-Arie Y; Cohen Y
    Harefuah; 2001 Apr; 140(4):311-5, 367. PubMed ID: 11303395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probability of cure in elderly Hodgkin's disease patients.
    Levis A; Depaoli L; Urgesi A; Bertini M; Orsucci L; Vitolo U; Buchi G; Gallamini A; Gavarotti P; Novarino A; Rota Scalabrini D; Mazza U; Pileri A; Sannazzari GL; Resegotti L
    Haematologica; 1994; 79(1):46-54. PubMed ID: 15378948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of Hodgkin's disease trial.
    Canellos GP; Niedzwiecki D
    N Engl J Med; 2002 May; 346(18):1417-8. PubMed ID: 11986425
    [No Abstract]   [Full Text] [Related]  

  • 28. Bendamustine combined regimen for Hodgkin's lymphoma.
    Venkatesan P
    Lancet Oncol; 2016 Aug; 17(8):e326. PubMed ID: 27425812
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recent progress in the chemotherapy of malignant lymphoma].
    Tobinai K
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):437-43. PubMed ID: 7887635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chemotherapy alone with adult chemotherapy regimens on prognosis of children and adolescents with Hodgkin's disease.
    Zhen Z; Guo X; Zhu J; Lu S; Sun F; Wang J; Huang J; Liao R; Sun X
    Jpn J Clin Oncol; 2016 Jul; 46(7):667-73. PubMed ID: 27162323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.
    Colonna P; Jais JP; Desablens B; Harousseau JL; Brière J; Boasson M; Lemevel A; Casassus P; Le Prisé PY; Guilhot F; Ghandour C; Lejeune F; Andrieu JM
    J Clin Oncol; 1996 Jun; 14(6):1928-35. PubMed ID: 8656262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
    Xing PY; Shi YK; He XH; Zhou LQ; Dong M; Yang JL; Liu P
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):692-7. PubMed ID: 23159084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant.
    Crump M; Smith AM; Brandwein J; Couture F; Sherret H; Sutton DM; Scott JG; McCrae J; Murray C; Pantalony D
    J Clin Oncol; 1993 Apr; 11(4):704-11. PubMed ID: 8478664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hodgkin's disease in children; treatment results with or without radiotherapy].
    van Bunningen BN; Dewit L; Bartelink H
    Ned Tijdschr Geneeskd; 1986 May; 130(20):928-9. PubMed ID: 3755223
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
    Baĭsogolov GD; Afanasova NV; Shakhtarina SV
    Med Radiol (Mosk); 1990 May; 35(5):10-3. PubMed ID: 2342405
    [No Abstract]   [Full Text] [Related]  

  • 38. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.
    Hasenclever D; Diehl V
    N Engl J Med; 1998 Nov; 339(21):1506-14. PubMed ID: 9819449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of chemotherapy with C-MOPP in Hodgkin's disease in stages III B and IV B].
    Larraín C; Cuchacovich M; Conte G
    Rev Med Chil; 1987 Sep; 115(9):842-6. PubMed ID: 3506277
    [No Abstract]   [Full Text] [Related]  

  • 40. [Modern pharmacotherapy of Hodgkin disease].
    Josting A; Behringer K; Engert A; Diehl V
    Internist (Berl); 2004 Jan; 45(1):93-101. PubMed ID: 14735247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.